Clinical Trial Update: Telaglenastat + Talazoparib In Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating telaglenastat in combination with talazoparib for metastatic prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Talazoparib (talazoparib)
• Telaglenastat (telaglenastat)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Prostate Cancer Metastatic | Phase 2 | Status: UNKNOWN